EUVIMEDEUVIMED entdecken
Crossref

Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor

Qiu-Xu Teng, Zi-Ning Lei, Jing-Quan Wang, Yuqi Yang, Zhuo-Xun Wu, Nikita Dilip Acharekar, Wei Zhang, Sabesan Yoganathan, Yihang Pan, John Wurpel, Zhe-Sheng Chen, Shuo Fang

Drug Resistance Updates · 2024-03 · 73 · 101028

DOI: 10.1016/j.drup.2023.101028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2024-03. Verfasst von Qiu-Xu Teng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Antineoplastic Agents, Phthalazines. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Pharmaceutical Sciences, St. John's University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsAntineoplastic AgentsPhthalazinesHumansAnimalsFemaleMiceRiboseATP Binding Cassette Transporter, Subfamily BPoly(ADP-ribose) Polymerase InhibitorsCell Line, TumorMolecular Docking SimulationDrug Resistance, NeoplasmATP Binding Cassette Transporter, Subfamily G, Member 2Neoplasm Proteins

Stichwörter der Autor:innen

A2780ABC transporterOvarian cancerPARP inhibitorTalazoparib

Substanzen

talazoparibRiboseATP Binding Cassette Transporter, Subfamily BPoly(ADP-ribose) Polymerase InhibitorsAntineoplastic AgentsABCG2 protein, humanATP Binding Cassette Transporter, Subfamily G, Member 2Neoplasm ProteinsPhthalazines

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA; Department of Oncology, The Seventh Affiliated Hospital Sun Yat-sen University, Shenzhen, Gua…
  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA; Institute of Plastic Surgery, Weifang Medical University, Weifang, Shandong 261041, PR China.
  • Department of Oncology, The Seventh Affiliated Hospital Sun Yat-sen University, Shenzhen, Guangdong 518107, PR China.
  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Electronic address: wurpelj@stjohns.edu.
  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Electronic address: chenz@stjohns.edu.

Förderung

  • National Natural Science Foundation of China
  • Department of Pharmaceutical Sciences, St. John's University

Zitieren

APA

Teng, Q. X., Lei, Z. N., Wang, J. Q., Yang, Y., Wu, Z. X., Acharekar, N. D., Zhang, W., Yoganathan, S., Pan, Y., Wurpel, J., Chen, Z. S., & Fang, S. (2024). Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor. Drug Resistance Updates, 73, 101028. https://doi.org/10.1016/j.drup.2023.101028

Vancouver

Teng QX, Lei ZN, Wang JQ, Yang Y, Wu ZX, Acharekar ND, et al. Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor. Drug Resistance Updates. 2024;73:101028. doi:10.1016/j.drup.2023.101028

BibTeX
@article{Teng2024,
  author = {Teng, Qiu-Xu and Lei, Zi-Ning and Wang, Jing-Quan and Yang, Yuqi and Wu, Zhuo-Xun and Acharekar, Nikita Dilip and Zhang, Wei and Yoganathan, Sabesan and Pan, Yihang and Wurpel, John and Chen, Zhe-Sheng and Fang, Shuo},
  title = {Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor},
  journal = {Drug Resistance Updates},
  year = {2024},
  volume = {73},
  pages = {101028},
  doi = {10.1016/j.drup.2023.101028}
}
Kostenlos starten →